Logo 6 a1e69dad97a22b9caa5aa6c606f6ea7f9e9b8c4d0352141ae8a7e9bed5512ee3
  • Antibodies
  • Assays/Kits
  • Proteins/Peptides
  • siRNAs/Functional Genomics
  • Biochemicals
  • cDNA Clones
  • Cell/Tissue/Blood Products
  • Genes
  • Images

FTIDC

Name FTIDC
Supplier R&D Systems
Catalog 5000
Prices $309.00
Sizes 10 mg
Cas Number 873551-53-2
Chemical Name 4-[1-(2-Fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-3,6-dihydro-N-methyl-N-(1-methylethyl)-1(2H)-pyridinecarboxamide
Formula C18H23FN6O
Molecular Weight 358.41
Purity >98%
Supplier Page Shop

Product References

Pharmacological effects of the metabotropic glutamate receptor 1 antagonist - Pharmacological effects of the metabotropic glutamate receptor 1 antagonist

Satow A, Maehara S, Ise S, Hikichi H, Fukushima M, Suzuki G, Kimura T, Tanak T, Ito S, Kawamoto H, Ohta H. J Pharmacol Exp Ther. 2008 Aug;326(2):577-86.

Pharmacological characterization of a new, orally active and potent allosteric - Pharmacological characterization of a new, orally active and potent allosteric

Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H. J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14.

Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as - Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as

Ito S, Satoh A, Nagatomi Y, Hirata Y, Suzuki G, Kimura T, Satow A, Maehara S, Hikichi H, Hata M, Kawamoto H, Ohta H. Bioorg Med Chem. 2008 Nov 15;16(22):9817-29.



Privacy
Terms
About us
Contact us

Copyright© 2025. All Rights Reserved